189 related articles for article (PubMed ID: 23020726)
21. Using patient-initiated study participation in the development of evidence for personalized cancer therapy.
Ambrose LF; Freedman J; Buetow K; Friend S; Schilsky RL
Clin Cancer Res; 2011 Nov; 17(21):6651-7. PubMed ID: 22046027
[TBL] [Abstract][Full Text] [Related]
22. Personalizing medicine: strategies for implementing the evaluation of anaplastic lymphoma kinase rearrangement in non-small-cell lung cancer in Portugal.
Araújo A; Coelho A; de Mello RA; Azevedo I; Soares M; Queiroga H; Teixeira E; Parente B; Barata F
Rev Port Pneumol; 2012; 18(5):244-6. PubMed ID: 22748945
[No Abstract] [Full Text] [Related]
23. Novel therapies for non-small cell lung cancer.
Donington JS; Koo CW; Ballas MS
J Thorac Imaging; 2011 May; 26(2):175-85. PubMed ID: 21508738
[TBL] [Abstract][Full Text] [Related]
24. Personalized treatments of cancer patients: a reality in daily practice, a costly dream or a shared vision of the future from the oncology community?
Arnedos M; Soria JC; Andre F; Tursz T
Cancer Treat Rev; 2014 Dec; 40(10):1192-8. PubMed ID: 25441102
[TBL] [Abstract][Full Text] [Related]
25. Personalized medicine for non-small-cell lung cancer.
Mok TS; Zhou Q; Leung L; Loong HH
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1601-11. PubMed ID: 20942631
[TBL] [Abstract][Full Text] [Related]
26. Large personalised medicine trial in lung cancer heralds new research partnership.
Torjesen I
BMJ; 2014 Apr; 348():g2837. PubMed ID: 24742663
[No Abstract] [Full Text] [Related]
27. Molecular biologic features of non-small cell lung cancer. Clinical implications.
Rusch VW; Dmitrovsky E
Chest Surg Clin N Am; 1995 Feb; 5(1):39-55. PubMed ID: 7743147
[TBL] [Abstract][Full Text] [Related]
28. Personalized targeted therapy in advanced non-small cell lung cancer.
Ma PC
Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS56-60. PubMed ID: 22614968
[TBL] [Abstract][Full Text] [Related]
29. Emerging science and therapies in non-small-cell lung cancer: targeting the MET pathway.
Kris MG; Arenberg DA; Herbst RS; Riely GJ
Clin Lung Cancer; 2014 Nov; 15(6):475. PubMed ID: 25306384
[TBL] [Abstract][Full Text] [Related]
30. [Diagnostic and predictive analyses of cytological specimens of non-small cell lung cancer: strategies and challenges].
Herth FJ; Bubendorf L; Gütz S; Morresi-Hauf A; Hummel M; Junker K; Lehmann U; Petersen I; Schnabel PA; Warth A
Pneumologie; 2013 Apr; 67(4):198-204. PubMed ID: 23576199
[TBL] [Abstract][Full Text] [Related]
31. Personalized peptide vaccination in patients with refractory non-small cell lung cancer.
Yoshiyama K; Terazaki Y; Matsueda S; Shichijo S; Noguchi M; Yamada A; Mine T; Ioji T; Itoh K; Shirouzu K; Sasada T; Takamori S
Int J Oncol; 2012 May; 40(5):1492-500. PubMed ID: 22307435
[TBL] [Abstract][Full Text] [Related]
32. Evaluation and treatment of patients with non-small cell lung cancer.
Carr LL; Finigan JH; Kern JA
Med Clin North Am; 2011 Nov; 95(6):1041-54. PubMed ID: 22032426
[TBL] [Abstract][Full Text] [Related]
33. [Therapy of bronchus carcinoma: therapeutic possibilities and current molecular biology trials].
Ludwig CU
Schweiz Med Wochenschr; 1990 Aug; 120(31-32):1143-8. PubMed ID: 1975458
[TBL] [Abstract][Full Text] [Related]
34. [EML4-ALK fusion in non-small-cell lung cancer].
Wang X; Bai CX
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Mar; 34(3):207-9. PubMed ID: 21569690
[No Abstract] [Full Text] [Related]
35. Exploring the future of non-small cell lung cancer treatment.
Ramalingam S
Manag Care; 2005 Feb; 14(2 Suppl):9-13; discussion 13-4. PubMed ID: 15776956
[No Abstract] [Full Text] [Related]
36. [Is lung cancer in women different?].
Ben Aissa A; Mach N
Rev Med Suisse; 2012 May; 8(342):1108-11. PubMed ID: 22734179
[TBL] [Abstract][Full Text] [Related]
37. Advances in personalized therapy for lung cancer.
Kim ES; Pandya KJ
Expert Opin Med Diagn; 2013 Sep; 7(5):475-85. PubMed ID: 23931094
[TBL] [Abstract][Full Text] [Related]
38. [Second-line treatment of metastatic non-small cell lung carcinoma: What are the options today? What are the perspectives for tomorrow?].
Greillier L; Barlesi F
Rev Mal Respir; 2012 Jan; 29(1):4-6. PubMed ID: 22240212
[No Abstract] [Full Text] [Related]
39. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
Dacic S
Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
[TBL] [Abstract][Full Text] [Related]
40. Cooperative group research efforts in lung cancer: focus on early-stage non-small-cell lung cancer.
Wakelee H; Langer C; Vokes E; Schiller J; Baas P; Saijo N; Adjei A; Shepherd F; Choy H; Gandara DR
Clin Lung Cancer; 2008 Jan; 9(1):9-15. PubMed ID: 18282352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
